FDA Enforcement Class II Terminated

VITROS Na+ Slides, (UPN 10758750004812) For in vitro diagnostic use only. VITROS Na+ Slides quantitatively measure sodium (Na+) concentration in serum, plasma, and urine using VITROS 250/350/950/5,1 FS and 4600 Chemistry Systems and the VITROS 5600 Integrated System.

Recall: Z-1117-2017 · Reported February 8, 2017

Enforcement

Recall Number
Z-1117-2017
Event ID
76119
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Ortho-Clinical Diagnostics
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
February 8, 2017
Initiation Date
December 20, 2016
Classification Date
January 31, 2017
Termination Date
June 22, 2018
Address
513 Technology Blvd, N/A, Rochester, NY, 14626-3601, United States

Description

VITROS Na+ Slides, (UPN 10758750004812) For in vitro diagnostic use only. VITROS Na+ Slides quantitatively measure sodium (Na+) concentration in serum, plasma, and urine using VITROS 250/350/950/5,1 FS and 4600 Chemistry Systems and the VITROS 5600 Integrated System.

Reason

There is a potential for biased results to be generated over the 10 day on-analyzer storage limit when using VITROS Na+ Slide cartridges warmed at room temperature and loaded onto the analyzer after using the minimum warm up requirements stated in the IFU. If Quality Control (QC) results are within acceptable limits, reported results are acceptable and were not affected by this issue.

Code Info

Generation (GEN): 1 through 6, 30 through 40, 44 through 49 Expiry Dates: 01-JAN-2017 through 01-JUN-2018

Distribution

Worldwide Distribution - USA (nationwide) Distribution and to the countries of : Bermuda, Australia, Brazil, Canada, Chile, China, Colombia, India, Japan, Mexico, Republic of Panama, Singapore, Venezuela, England, France, Germany, Italy, Spain and Poland.

Quantity

659,957 Total Units (249,570 units domestically & 410,387 units internationally)